|LETTER TO EDITOR
|Year : 2020 | Volume
| Issue : 1 | Page : 68
Candida auris candidemia – An emerging threat: A case report and mini-review of the literature
Mahmood Dhahir Al-Mendalawi
Department of Paediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq
|Date of Submission||17-Jan-2020|
|Date of Decision||05-Mar-2020|
|Date of Acceptance||22-Mar-2020|
|Date of Web Publication||20-Jul-2020|
Mahmood Dhahir Al-Mendalawi
P.O. Box 55302, Baghdad Post Office, Baghdad
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Al-Mendalawi MD. Candida auris candidemia – An emerging threat: A case report and mini-review of the literature. J Curr Res Sci Med 2020;6:68
|How to cite this URL:|
Al-Mendalawi MD. Candida auris candidemia – An emerging threat: A case report and mini-review of the literature. J Curr Res Sci Med [serial online] 2020 [cited 2020 Aug 3];6:68. Available from: http://www.jcrsmed.org/text.asp?2020/6/1/68/290247
I read with interest the case report by Bhat et al. published in the July–December 2019 issue of the Journal of Current Research in Scientific Medicine. The authors studied a case of the Candida auris candidemia in an Indian patient. The authors attributed the escalating clinical course culminating in death to the presence of numerous comorbidities in the studied patient, namely obstructive sleep apnea, rheumatic heart disease with mitral stenosis, cholelithiasis, and hypothyroidism. I assume that the following point might be contributory. It is obvious that due to defective immune system, individuals with human immunodeficiency virus (HIV) infection are more liable to various types of fungal infections compared to the individuals with intact immune system. Truly, fungal infections among HIV-positive individuals tend to be invasive and often run protracted clinical progressions. In India, HIV infection is a worrisome health threat. The available data pointed out that the national adult HIV seroprevalence was estimated at 0.22% (0.16%–0.30%) in 2017. I presume that underlying HIV infection ought to be seriously considered in the case in question and diagnostic algorithm for HIV detection would have solicited. If that algorithm was to disclose HIV seropositivity, the case in question could be obviously regarded a novel case report. This is because C. auris fungal isolate has never been reported among Indian patients infected with HIV. Regrettably, the studied patient succumbed before considering HIV testing.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Bhat KS, Kisku KH, Kanungo R. Candida auris
candidemia an emerging threat: A case report and mini review of the literature. J Curr Res Sci Med 2019;5:110-3. [Full text]
Guarner J. Human immunodeficiency virus and fungal infections. Semin Diagn Pathol 2017;34:325-31.
Government of India, Ministry of Health and Family Welfare, National Aids Control Organisation. HIV Facts and Figures. Available from: http://naco.gov.in/hiv-facts-figures
. [Last accessed on 2020 Jan 16].
Maheshwari M, Kaur R, Chadha S. Candida
Species prevalence profile in HIV seropositive patients from a major tertiary care hospital in New Delhi, India. J Pathog 2016;2016:6204804.